<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1348128</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1348128</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Evaluation of binding mechanism of dietary phytochemical, capsaicin, with human transferrin: targeting neurodegenerative diseases therapeutics</article-title>
<alt-title alt-title-type="left-running-head">Alrouji et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1348128">10.3389/fphar.2024.1348128</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Alrouji</surname>
<given-names>Mohammed</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2154631/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alhumaydhi</surname>
<given-names>Fahad A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/930556/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Venkatesan</surname>
<given-names>Kumar</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2593840/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharaf</surname>
<given-names>Sharaf E.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2587509/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shahwan</surname>
<given-names>Moyad</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/811987/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shamsi</surname>
<given-names>Anas</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/943583/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Medical Laboratories</institution>, <institution>College of Applied Medical Sciences</institution>, <institution>Shaqra University</institution>, <addr-line>Shaqra</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Medical Laboratories</institution>, <institution>College of Applied Medical Sciences</institution>, <institution>Qassim University</institution>, <addr-line>Buraydah</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pharmaceutical Chemistry</institution>, <institution>College of Pharmacy</institution>, <institution>King Khalid University</institution>, <addr-line>Abha</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Pharmaceutical Sciences Department</institution>, <institution>College of Pharmacy</institution>, <institution>Umm Al-Qura University</institution>, <addr-line>Makkah</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Centre of Medical and Bio-allied Health Sciences Research</institution>, <institution>Ajman University</institution>, <addr-line>Ajman</addr-line>, <country>United Arab Emirates</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1400061/overview">Nermi Parrow</ext-link>, Saint Louis University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/414486/overview">Tabish Rehman</ext-link>, King Saud University, Saudi Arabia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1909456/overview">Prabhakar Singh</ext-link>, Sathyabama Institute of Science and Technology, India</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Anas Shamsi, <email>anas.shamsi18@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1348128</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Alrouji, Alhumaydhi, Venkatesan, Sharaf, Shahwan and Shamsi.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Alrouji, Alhumaydhi, Venkatesan, Sharaf, Shahwan and Shamsi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Human transferrin (htf) plays a crucial role in regulating the balance of iron within brain cells; any disruption directly contributes to the development of Neurodegenerative Diseases (NDs) and other related pathologies, especially Alzheimer&#x2019;s Disease (AD). In recent times, a transition towards natural compounds is evident to treat diseases and this shift is mainly attributed to their broad therapeutic potential along with minimal side effects. Capsaicin, a natural compound abundantly found in red and chili peppers, possess neuroprotective potential. The current work targets to decipher the interaction mechanism of capsaicin with htf using experimental and computational approaches. Molecular docking analysis revealed that capsaicin occupies the iron binding pocket of htf, with good binding affinity. Further, the binding mechanism was investigated atomistically using Molecular dynamic (MD) simulation approach. The results revealed no significant alterations in the structure of htf implying the stability of the complex. <italic>In silico</italic> observations were validated by fluorescence binding assay. Capsaicin binds to htf with a binding constant (<italic>K</italic>) of 3.99 &#xd7; 10<sup>6</sup>&#xa0;M<sup>&#x2212;1</sup>, implying the stability of the htf-capsaicin complex. This study lays a platform for potential applications of capsaicin in treatment of NDs in terms of iron homeostasis.</p>
</abstract>
<kwd-group>
<kwd>neurodegenerative diseases</kwd>
<kwd>human transferrin</kwd>
<kwd>natural compounds</kwd>
<kwd>fluorescence spectroscopy</kwd>
<kwd>molecular dynamics simulation</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Translational Pharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Alzheimer&#x2019;s disease (AD) is responsible for 80% of dementia cases, implying the burden this Neurodegenerative disease (ND) is posing in current times (<xref ref-type="bibr" rid="B32">Posner et al., 2002</xref>). AD is a progressive, long-term neurological illness, clinically defined by cognitive impairment in several domains, namely, behavior, language, memory, and visuospatial ability (<xref ref-type="bibr" rid="B4">Caballol et al., 2007</xref>; <xref ref-type="bibr" rid="B10">Dumurgier and Sabia, 2021</xref>). The two major hallmarks associated with onset of AD are accumulation of amyloid beta peptide as senile plaques and pathological hyperphosphorylation of the tau protein, leading to the generation of neurofibrillary tangles (NFTs) (<xref ref-type="bibr" rid="B24">Malafaia et al., 2021</xref>; <xref ref-type="bibr" rid="B46">Wegmann et al., 2021</xref>). Even though decades of study have not been able to pinpoint the exact etiological causes, it is now understood that AD pathogenesis is intricate and multifaceted.</p>
<p>As of right now, FDA-approved drugs merely temporarily stop the symptoms; they don&#x2019;t stop the disease&#x2019;s underlying course. Cholinesterase inhibitors such as donepezil and memantine, as well as NMDA receptor blockers, are approved choices (<xref ref-type="bibr" rid="B5">Calhoun et al., 2018</xref>). Lecanemab is a recently approved medication, albeit with some drawbacks. Several studies focusing on tau, amyloid, and other disease pathways try to alter the illness. It is likely that combination therapy will be required due to the complex reasons. In addition to medication-based strategies, lifestyle changes like social engagement, physical activity, and cognitive training may help postpone cognitive deterioration (<xref ref-type="bibr" rid="B47">Williams and Kemper, 2010</xref>). Globally, dementia is thought to affect approximately 55 million people, and by 2050, that number is expected to quadruple, posing a serious threat to public health.</p>
<p>Although iron is a necessary mineral, too much of it can cause oxidative stress and brain cell damage (<xref ref-type="bibr" rid="B31">Peng et al., 2021</xref>; <xref ref-type="bibr" rid="B50">Zhang et al., 2021</xref>). In order to preserve the ideal balance, iron levels are therefore strictly controlled in the brain. Abnormal iron accumulation has been found in the brains of AD patients, particularly among microglia, tau tangles, and amyloid plaques, according to imaging and histology studies. Numerous processes can result in neuronal injury from elevated iron levels. It catalyzes the production of reactive oxygen species, including hydroxyl radicals, which damage proteins, lipids, and genetic material. Additionally, too much iron encourages amyloid-beta to group together to produce harmful oligomers and fibrils that result in plaques (<xref ref-type="bibr" rid="B44">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="B29">Onukwufor et al., 2022</xref>; <xref ref-type="bibr" rid="B43">Wang et al., 2022</xref>). It might also affect abnormal hyperphosphorylation of tau, which would lead to tau misfolding and knotted clusters. In the meantime, normal iron-regulating proteins are disrupted by amyloid and tau clumps, which lead to additional iron imbalances and elevated oxidative stress in a vicious cycle of degeneration (<xref ref-type="bibr" rid="B7">Chen et al., 2017</xref>). Excess iron accumulates at the molecular level in mitochondria, interfering with the electron transport chain and preventing cells from producing energy. It also tampers with neurons&#x2019; ability to digest lipids. High iron levels in microglial cells cause oxidative damage and toxicity to spread to other neurons by inducing a pro-inflammatory state. Increased neuronal death and the loss of synaptic connections between neurons have been related to dysregulation of iron metabolism (<xref ref-type="bibr" rid="B14">Gleitze et al., 2021</xref>). Increased &#x201c;redox-active iron deposits&#x201d; in the hippocampus are correlated with declining cognitive function in AD patients, according to neuroimaging data. Restoring equilibrium in iron control and reducing iron-catalyzed oxidative stress may mitigate AD-induced synaptic and neuronal damage. All these reports emphasize the deleterious effects of excessive signifying the importance of keeping a check on iron levels and this is largely maintained by Human transferrin (htf). A glycoprotein that is mostly produced in the liver, htf is essential for maintaining iron homeostasis. It moves iron from places of absorption, storage, and cellular utilization via the circulation. It transports iron to cells without enabling toxicity by binding ferric iron firmly yet reversibly. Although iron is necessary for several essential bodily processes, too much of it can be hazardous. Iron is transported and regulated throughout the body, including the brain, by htf. Elevated iron levels raise the amount of non-htf bound iron and induce htf to saturate, which can result in an iron buildup in tissues (<xref ref-type="bibr" rid="B16">Gosriwatana et al., 1999</xref>; <xref ref-type="bibr" rid="B20">Leverence et al., 2010</xref>). Within the brain, there are receptors on the endothelial cells of the blood brain barrier that binds htf, thereby controlling iron entry into the brain (<xref ref-type="bibr" rid="B9">DeGregorio-Rocasolano et al., 2019</xref>). Further to avoid the toxicity, it also controls iron release from glial cells and neurons (<xref ref-type="bibr" rid="B45">Ward et al., 2014</xref>). There is a rare ND wherein iron accumulates in the brain has and it has been connected to mutations in the htf gene reducing the protein&#x2019;s affinity for iron.</p>
<p>In recent times, many studies have reported that there are number of plant derived substances and dietary components that may be useful in AD therapeutics. Polyphenols are usually found in fruits, vegetables, tea, coffee, and herbs and possess variety of neuroprotective properties, namely, the reduction of amyloid and tau lesions, limiting neuroinflammation, simulating brain plasticity and connections, and reducing oxidative stress. Studies show that populations with high polyphenols consumption shows reduced incidences of AD (<xref ref-type="bibr" rid="B18">Jiang et al., 2013</xref>; <xref ref-type="bibr" rid="B30">Ozcan et al., 2014</xref>; <xref ref-type="bibr" rid="B41">Uddin et al., 2020</xref>).</p>
<p>Capsicum genus plants contain capsaicin (8-methyl-N-vanillyl-6-nonenamide), a hydrophobic, spicy-tasting transient receptor potential vanilloid 1 (TRPV1)-receptor agonist (<xref ref-type="bibr" rid="B6">Chang et al., 2011</xref>; <xref ref-type="bibr" rid="B15">Gonzalez-Mondragon and Vazquez-Tzompantzi, 2011</xref>). People frequently use capsicum in their meals due to its flavor and spice. The daily intake of capsaicin is estimated to range from 1.5&#xa0;mg per person in the US and Europe to 25&#xa0;mg per person in India and 200&#xa0;mg per person in Mexico (<xref ref-type="bibr" rid="B33">Rollyson et al., 2014</xref>). According to animal studies, 50%&#x2013;90% of capsaicin is available orally. Capsaicin passes the blood-brain barrier, as demonstrated by animal research, which is necessary for it to be taken into consideration for AD treatment. From a physiological perspective, capsaicin is well known for its capacity to elicit pain and sensitize peripheral and central nerves, resulting in symptoms that resemble neuropathic pain, including visceral hyperalgesia, secondary hyperalgesia, transferred pain region, and allodynia.</p>
<p>Capsaicin is widely used as a topical analgesic (<xref ref-type="bibr" rid="B11">Fattori et al., 2016</xref>), neuro-protectant, reduces oxidative stress and enhances apoptosis in epilepsy and ischemic injury (<xref ref-type="bibr" rid="B19">Khatibi et al., 2011</xref>; <xref ref-type="bibr" rid="B1">Abdel-Salam et al., 2020</xref>). It also reduces inflammation (<xref ref-type="bibr" rid="B38">Tang et al., 2015</xref>; <xref ref-type="bibr" rid="B36">Shang et al., 2017</xref>) and exhibits antioxidant properties (<xref ref-type="bibr" rid="B12">Galano and Mart&#xed;nez, 2012</xref>; <xref ref-type="bibr" rid="B23">Lu et al., 2020</xref>). Capsaicin has been demonstrated recently to reduce tau hyperphosphorylation in rats with Type 2 diabetes (T2D) after they received an injection of a streptozocin AD model (<xref ref-type="bibr" rid="B48">Xu et al., 2017</xref>). Spicy food consumption has been linked to improved cognitive function in humans, and in non-AD subjects, reduces CSF phospho-tau/A&#x3b2;1-42 and total tau/A&#x3b2;1-42 ratios have been reported (<xref ref-type="bibr" rid="B21">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B39">Tian et al., 2021</xref>). All these reports signify the importance of capsaicin in NDs therapeutics. Thus, <italic>in lieu</italic> of the importance of htf and capsaicin in NDs therapeutics, the current work targets to decipher the binding mechanism of capsaicin with htf through computational and experimental approaches. The binding of capsaicin with htf was delineated at atomistic level using molecular docking and molecular dynamic simulation approaches and further validated by fluorescence spectroscopic technique.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Materials</title>
<p>htf and capsaicin were purchased from Sigma Aldrich (St. Loius, United States). We prepared a stock solution of htf and it was subjected to further dilution for working concentrations. All the chemicals used for buffer preparation were obtained from HiMedia. We used quartz cuvettes for spectroscopic assays.</p>
</sec>
<sec id="s2-2">
<title>Molecular docking</title>
<p>Molecular docking was employed to explore the binding affinity and interaction between htf and capsaicin. The structure of htf (PDB accession: 3V83) was extracted from the RCSB Protein Data Bank with. The ligand structure was retrieved from the PubChem database with CID: 1548943. The structures were processed utilizing MGL AutoDock tools (<xref ref-type="bibr" rid="B17">Huey et al., 2012</xref>). Molecular docking was carried out using InstaDock v1.2 to investigate detailed binding of capsaicin with htf. Htf (<xref ref-type="bibr" rid="B27">Mohammad et al., 2021</xref>). We used a blind search space strategy to ensure thorough exploration of potential binding sites within the protein. was employed. For the experiment, the grid coordinates were set at 82&#xa0;&#xc5; for the X-axis, 99&#xa0;&#xc5; for the Y-axis, and 84&#xa0;&#xc5; for the Z-axis, with the central coordinates defined as follows: &#x2212;52.355 along the X-axis, 17.601 along the Y-axis, and &#x2212;30.21 along the Z-axis. We used a grid spacing of 1&#xa0;&#xc5; and retorted employed Discovery Studio Visualizer and PyMol to carry out post docking visualization.</p>
</sec>
<sec id="s2-3">
<title>MD simulations</title>
<p>Molecular dynamic (MD) simulation studies were performed under a constant temperature of 300&#xa0;K, using the &#x201c;charmm36-jul2022&#x201d; force field within the &#x201c;GROMACS suite version 2020-&#x3b2;&#x201d; (<xref ref-type="bibr" rid="B42">Van Der Spoel et al., 2005</xref>). The best pose that was obtained from docking studies was used as a starting structure. Ligand topology was created through the CHARMM CGenFF program. Subsequently, the integration of the ligand topology with the initial coordinates of htf was carried out using CGenFF Python script to ensure proper configuration of the system. After that the solvent molecules were introduced in the system by utilizing a 1&#xa0;nm cubic box and the solvation was executed using the <italic>gmx solvate</italic> command, employing SPC216 solvent in GROMACS (<xref ref-type="bibr" rid="B13">Gl&#xe4;ttli et al., 2002</xref>). Post that energy minimization was carried out using the steepest descent approach to refine the systems. The resulting trajectories were investigated using various GROMACS modules, including <italic>gmx rms, gmx rmsf, gmx gyrate, gmx sasa, gmx sham</italic>, etc. The graphs and visual representations were generated using QtGrace (<xref ref-type="bibr" rid="B40">Turner, 2005</xref>).</p>
</sec>
<sec id="s2-4">
<title>Fluorescence spectroscopy</title>
<p>We employed fluorescence binding study to check the actual binding of capsaicin with htf in line with earlier studies on Shimadzu Spectrofluorophotometer (RF-6000). The concentration of htf was kept constant (4&#xa0;&#xb5;M) and capsaicin was varied in the range of 0&#x2013;6&#xa0;&#xb5;M. The data obtained was put into Modified Stern&#x2013;Volmer (MSV) equation as per earlier literature to obtain the binding constant (<italic>K</italic>) of Htf-capsaicin complex (<xref ref-type="bibr" rid="B35">Shamsi et al., 2020</xref>). We carried out the experiment in triplicates and mean value was taken into account. All the spectra reported here are the subtracted spectra after considering the fluorescence of capsaicin by taking a blank spectra of the ligand.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Molecular docking</title>
<p>The outcomes derived from our molecular docking study have uncovered a robust interaction between capsaicin and htf, emphasizing it to be a potential binding partner. This docking analysis has furnished better comprehension of the binding mode of capsaicin with htf, allowing for the recognition of critical residues involved in this interaction. The computed affinity for the htf-capsaicin was found to be &#x2212;5.9&#xa0;kcal/mol, accompanied by a ligand efficiency of 0.2682&#xa0;kcal/mol per non-hydrogen atom. Building upon the observed binding affinity, we conducted an exhaustive analysis to explore the potential interactions stabilizing the htf-capsaicin complex. This analysis has provided a clear understanding of capsaicin&#x2019;s binding mechanism against htf, highlighting its preference for occupying htf&#x2019;s iron-binding pocket, strategically positioned within the deep cavity of htf (<xref ref-type="fig" rid="F1">Figure 1A</xref>). This positioning establishes significant connections with residues located in the binding pocket, as depicted in <xref ref-type="fig" rid="F1">Figure 1B</xref>. Notably, three hydrogen bonds are formed with Glu442, Ala443, and Gly444, crucial residues in close proximity to htf&#x2019;s iron-binding site (<xref ref-type="bibr" rid="B28">Noinaj et al., 2012</xref>). Visual representations of the surface further accentuate capsaicin&#x2019;s presence within htf&#x2019;s internal cavity, as shown in <xref ref-type="fig" rid="F1">Figure 1B</xref>. Moreover, a range of significant interactions, including the iron-binding site Tyr445, contributes to the stability of the protein-ligand complex, as illustrated in <xref ref-type="fig" rid="F1">Figure 1C</xref>. Earlier studies have similarly reported binding of iron in vicinity of these crucial residues (<xref ref-type="bibr" rid="B28">Noinaj et al., 2012</xref>). Therefore, a reasonable hypothesis can be proposed that capsaicin docks in close proximity to htf&#x2019;s iron-binding pocket, establishing stable interactions with various binding site residues within htf.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Analysis of protein-ligand interactions. <bold>(A)</bold> Binding of capsaicin with htf. <bold>(B)</bold> Depiction of capsaicin docking and its interaction with the binding site residues of htf. <bold>(C)</bold> Visualization of the surface potential within the htf binding pocket, featuring capsaicin occupancy.</p>
</caption>
<graphic xlink:href="fphar-15-1348128-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Htf dynamics upon capsaicin binding</title>
<p>MD simulation is extensively utilized to explore the dynamic motions and conformational changes of macromolecules over a defined time frame. Here, we performed thorough MD simulations, spanning a duration of 200&#xa0;ns, for htf and htf-capsaicin complex. Our primary aim was to explore conformational alterations, system stability, and the dynamics of interaction involved in the binding of capsaicin with htf. To assess structural dynamics, we employed the commonly used metric known as the root mean square deviation (RMSD) (<xref ref-type="bibr" rid="B26">Maruyama et al., 2023</xref>). The RMSD values for htf and htf-capsaicin complex did not reveal significant differences, suggesting that the capsaicin binding stabilizes htf without affecting its native conformation (<xref ref-type="fig" rid="F2">Figure 2A</xref>). However, there were some initial fluctuations in RMSD in the first frame of 50&#xa0;ns. The observed fluctuations can reasonably be attributed to the initial orientation of capsaicin within htf&#x2019;s binding pocket. Subsequent to this initial phase, the RMSD of the htf-capsaicin complex stabilizes, emphasizing the sustained stability of the protein-ligand complex (<xref ref-type="fig" rid="F2">Figure 2A</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Dynamics of htf structure in the presence of capsaicin. <bold>(A)</bold> Root mean square deviation (RMSD), <bold>(B)</bold> Root mean square fluctuation (RMSF), <bold>(C)</bold> Radius of gyration (<italic>R</italic>g), and <bold>(D)</bold> Solvent accessible surface area (SASA) plots. The black and green correspond to the values obtained for free htf and htf-Capsaicin complexes, respectively.</p>
</caption>
<graphic xlink:href="fphar-15-1348128-g002.tif"/>
</fig>
<p>We assessed local structural characteristics and the flexibility of each residue in the protein structure by conducting root-mean-square fluctuation (RMSF) calculations for free htf and capsaicin bound htf its (<xref ref-type="fig" rid="F2">Figure 2B</xref>). The obtained RMSF plots show that there are variations in residue flexibility across htf. RMSF of htf persists fairly constant upon the binding of capsaicin, in a way showing intermittent fluctuations and stabilization peaks throughout the structure. Upon capsaicin binding, there was an elevation in residue fluctuations, specifically in the &#x201c;N-terminal region,&#x201d; where capsaicin is not bound. The occurrence of this phenomenon is attributable to the residual vibrations persisting throughout the course of simulation.</p>
<p>The radius of gyration (<italic>R</italic>
<sub>g</sub>) is a vital parameter that demonstrates protein&#x2019;s conformational structure (<xref ref-type="bibr" rid="B22">Lobanov et al., 2008</xref>). The average <italic>R</italic>
<sub>g</sub> for htf and the htf-capsaicin complex was between 2.9&#xa0;nm and 3.0&#xa0;nm. The value of <italic>R</italic>
<sub>g</sub> for the htf-capsaicin complex was slightly lower in comparison to free htf and this was constant throughout the simulation (<xref ref-type="fig" rid="F2">Figure 2C</xref>). The <italic>R</italic>
<sub>g</sub> plots depicted modest shifts with no major structural rearrangements in htf post capsaicin binding. This implies that binding of capsaicin induced higher stability in the native conformation of htf.</p>
<p>Additionally, Solvent-accessible surface area (SASA) was calculated for protein alone and in complex with ligand. SASA sheds light on the extent of a protein&#x2019;s surface engagement with the surrounding solvent environment (<xref ref-type="bibr" rid="B25">Marsh and Teichmann, 2011</xref>). The calculated SASA values for protein alone and in complex with htf bound capsaicin ranged from 295&#xa0;nm<sup>2</sup> to 315&#xa0;nm<sup>2</sup>, respectively. A subtle reduction in SASA was observed implying that there is a degree of conformational stability in htf upon capsaicin binding (<xref ref-type="fig" rid="F2">Figure 2D</xref>). This marginal decline in SASA implies conformational stability in the htf resulting from capsaicin binding, i.e., ligand occupies some intramolecular space of the protein.</p>
</sec>
<sec id="s3-3">
<title>Stabilization of htf-capsaicin complex</title>
<p>Integral hydrogen bonding plays a pivotal role in maintaining protein stability and can introduce directionality to interactions between proteins and ligands (<xref ref-type="bibr" rid="B49">Yunta, 2017</xref>). In the context of this study, we conducted an exhaustive examination of the stability of htf and htf-capsaicin complex. This investigation encompassed the quantification of hydrogen bonds formed within the protein structure throughout the simulation duration, as depicted in <xref ref-type="fig" rid="F3">Figure 3A</xref>. Significantly, a subtle reduction in the number of hydrogen bonds becomes apparent upon the binding of capsaicin. In contrast, htf and capsaicin consistently maintaining 2&#x2013;3 intermolecular hydrogen bonds throughout the simulation, as depicted in <xref ref-type="fig" rid="F3">Figure 3B</xref>. Within htf&#x2019;s binding pocket, the interaction with capsaicin was noted to involve 7&#x2013;8 hydrogen bonds with increased fluctuations and 2&#x2013;3 hydrogen bonds up to 130&#xa0;ns, followed by 4&#x2013;6 hydrogen bonds after 130&#x2013;200&#xa0;ns, demonstrating relatively enhanced stability. A detailed examination of hydrogen bonding patterns facilitates a deeper understanding of the stability of the interaction within the htf-capsaicin complex.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Dynamics of hydrogen bond formation. <bold>(A)</bold> Intra-htf hydrogen bonds, and <bold>(B)</bold> Intermolecular hydrogen bonds between capsaicin and htf.</p>
</caption>
<graphic xlink:href="fphar-15-1348128-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Principal component analysis</title>
<p>Proteins function through intricate atomic movements, and employing principal component analysis (PCA) offers a valuable approach to unraveling fundamental dynamics by pinpointing key principal motions (<xref ref-type="bibr" rid="B37">Stein et al., 2006</xref>). This approach has the capacity to illuminate insights into protein stability. In our exploration of the dynamic conformational behaviors of htf and the htf-capsaicin complex, we employed PCA and visually illustrated the changes in the conformation within the essential subspace (<xref ref-type="fig" rid="F4">Figures 4A, B</xref>). Interestingly, with the introduction of capsaicin, htf demonstrates a cluster of stable states, suggesting a minor reduction in conformational exploration compared to its unbound state (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Overall, the results indicated that htf remained stable before and after capsaicin binding during the simulation trajectory.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>
<bold>(A)</bold> 2D representations of htf conformations and <bold>(B)</bold> the temporal evolution of these conformations.</p>
</caption>
<graphic xlink:href="fphar-15-1348128-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Free energy landscape analysis</title>
<p>To enhance our understanding of conformational dynamics, we conducted an in-depth exploration of the free energy landscapes (FELs) derived from the MD trajectories. <xref ref-type="fig" rid="F5">Figure 5</xref> vividly illustrates the FELs for htf and htf-capsaicin complex. In the unbound state of htf, the FEL shows a singular and consistently stable global minimum, primarily confined within a large single basin (<xref ref-type="fig" rid="F5">Figure 5A</xref>). This suggests a well-defined and stable conformational state for htf when not bound to capsaicin. Upon the introduction of capsaicin, the overall conformational behavior of htf undergoes examination (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Strikingly, there is no significant alteration observed, indicating that capsaicin binding does not induce substantial changes in the conformational landscape of htf. The presence of capsaicin, as depicted in the FELs, expands the spectrum of conformational space discovered by htf, suggesting potential influences on its functional dynamics. This stability is crucial in understanding the molecular intricacies governing the interaction between htf and capsaicin and its potential implications for functional dynamics.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Gibbs&#x2019; Free energy landscapes for <bold>(A)</bold> htf and <bold>(B)</bold> htf-capsaicin.</p>
</caption>
<graphic xlink:href="fphar-15-1348128-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Fluorescence spectroscopy</title>
<p>Fluorescence spectroscopy ascertains the actual binding affinity of ligand with the protein. For htf, tryptophan alone is main player in the intrinsic fluorescence; tyrosine&#x2019;s fluorescence undergoes complete quenching when subjected to ionization or when in proximity to an &#x201c;amino group,&#x201d; a &#x201c;carboxyl group,&#x201d; or another tryptophan residue; phenylalanine has the lowest quantum yield. <italic>In silico</italic> observations showed the formation of stable htf-capsaicin complex. In a bid to further validate these computational observations, fluorescence binding studies were carried out. Intrinsic fluorescence of htf is very responsive to its micro-environment (<xref ref-type="bibr" rid="B34">Sarzehi and Chamani, 2010</xref>); any minimal changes in the microenvironment around its fluorophores results in corresponding changes in the fluorescence spectra. We excited htf at 280&#xa0;nm, and it was found to show characteristic peak at around 335&#xa0;nm, suggestive of the fact that htf is in its native form. The protein&#x2019;s fluorescence intensity might decrease due to inner filter effect, which happens when the solution absorbs light at the excitation (&#x3bb;<sub>ex</sub>) and emission (&#x3bb;<sub>em</sub>) wavelengths and thus &#x201c;inner filter&#x2019;s effect&#x201d; on the fluorescence intensity was adjusted as per earlier reported studies (<xref ref-type="bibr" rid="B8">Chi and Liu, 2011</xref>). With increasing concentrations of capsaicin, a corresponding decrease in the fluorescence intensity was observed, a phenomenon referred to as fluorescence quenching (<xref ref-type="fig" rid="F6">Figure 6A</xref>). This dose dependent decrease fluorescence intensity in the presence of capsaicin is suggestive of the formation of htf-capsaicin complex, validating our <italic>in silico</italic> observations. We fitted the quenching data into MSV equation to obtain MSV plot (<xref ref-type="fig" rid="F6">Figure 6B</xref>) with its intercept giving the binding constant of the complex. Capsaicin demonstrated significant binding with htf with a <italic>K</italic> of 3.99 &#xd7; 10<sup>6</sup>&#xa0;M<sup>&#x2212;1</sup>. The computed <italic>K</italic> value fall within the reported range for other protein-ligand complexes (<xref ref-type="bibr" rid="B2">Alhumaydhi et al., 2021</xref>; <xref ref-type="bibr" rid="B3">Anwar et al., 2021</xref>), indicating a substantial strength of interaction between capsaicin and htf. In conclusion, fluorescence spectroscopy along with molecular docking and molecular dynamics simulation approaches affirms the fact that capsaicin binds to htf with a significant affinity forming a stable htf-capsaicin complex.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>
<bold>(A)</bold> Fluorescence emission spectra of native htf in absence and presence of capsaicin. <bold>(B)</bold> MSV plot of htf-capsaicin complex.</p>
</caption>
<graphic xlink:href="fphar-15-1348128-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Our comprehensive investigation harnessed an integrated approach utilizing docking and MD simulation along with fluorescence spectroscopy, to decipher the binding of capsaicin with htf. The robust interaction between capsaicin and htf, characterized by binding affinity of &#x2212;5.9&#xa0;kcal/mol, firmly underscored capsaicin&#x2019;s potential as htf&#x2019;s binding partner. An in depth analysis revealed the key residues governing this interaction; capsaicin forms three hydrogen bonds with critical residues Glu442, Ala443, and Gly444, in close proximity to htf&#x2019;s iron-binding site. This finding hints at a potential impact of capsaicin&#x2019;s binding on iron coordination and transport, providing a nuanced understanding of the molecular mechanisms at play.</p>
<p>Subsequent MD simulations spanning htf and htf-capsaicin complex over 200&#xa0;ns illuminated stability and conformational dynamics. The RMSD analysis indicated stable and sustained conformational changes in htf upon capsaicin binding, reinforcing the notion of complex stability. Notably, heightened fluctuations in residues, particularly within the N-terminal region, suggested localized flexibility introduced by capsaicin binding while preserving overall stability. The <italic>R</italic>g and SASA study provided additional insights into the conformational changes triggered by capsaicin binding. The minimal alterations in overall protein conformation, indicated by a slight increase in <italic>R</italic>g values, further supported the notion of stability. Minor fluctuations in hydrogen bond formation underscored the dynamic nature of the complex, emphasizing the critical role of hydrogen bonds in sustaining stability. PCA indicated that capsaicin binding expanded the range of conformational states explored by htf, suggesting a broader conformational space. The FEL analyses further supported the stability in the conformational behavior of htf initiated by capsaicin binding. Further, fluorescence spectroscopic observations corroborate with <italic>in silico</italic> observations affirming the formation of stable htf-capsaicin complex. In summary, our study has provided a comprehensive analysis of the htf-capsaicin complex, shedding light on its binding affinity, stability, and conformational dynamics. Capsaicin has been identified as a potent htf binding partner, displaying a robust interaction within the iron-binding pocket. The study further elucidates the complex&#x2019;s stability through a detailed examination of the intricate hydrogen bonding network. The findings from this investigation establish a solid groundwork for future investigations into capsaicin&#x2019;s therapeutic potential to treat NDs in context of iron proteins. This research contributes significantly to our understanding of the nuanced interplay between htf and capsaicin, offering valuable insights for potential therapeutic applications.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>MA: Conceptualization, Methodology, Validation, Writing&#x2013;original draft, Software. FA: Validation, Formal Analysis, Investigation, Writing&#x2013;review and editing. KV: Formal Analysis, Investigation, Validation, Funding acquisition, Writing&#x2013;original draft. SS: Formal Analysis, Validation, Writing&#x2013;original draft, Data curation, Supervision. MS: Data curation, Validation, Writing&#x2013;review and editing. AS: Data curation, Validation, Writing&#x2013;review and editing, Conceptualization, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing&#x2013;original draft.</p>
</sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through Large Groups Project under grant number (RGP.2/125/44). MA would like to thank the Deanship of Scientific Research at Shaqra University for supporting this work. AS is thankful to Ajman University, UAE for supporting this publication.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Salam</surname>
<given-names>O. M.</given-names>
</name>
<name>
<surname>Sleem</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Sayed</surname>
<given-names>M. a.E. B. M.</given-names>
</name>
<name>
<surname>Youness</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Shaffie</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Capsaicin exerts anti-convulsant and neuroprotective effects in pentylenetetrazole-induced seizures</article-title>. <source>Neurochem. Res.</source> <volume>45</volume>, <fpage>1045</fpage>&#x2013;<lpage>1061</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-020-02979-3</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alhumaydhi</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Aljasir</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Aljohani</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Alsagaby</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Alwashmi</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Shahwan</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Probing the interaction of memantine, an important Alzheimer&#x27;s drug, with human serum albumin: <italic>in silico</italic> and <italic>in vitro</italic> approach</article-title>. <source>J. Mol. Liq.</source> <volume>340</volume>, <fpage>116888</fpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2021.116888</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anwar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shamsi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anjum</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shafie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Structure&#x2010;based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases</article-title>. <source>J. Cell. Biochem.</source> <volume>122</volume>, <fpage>1445</fpage>&#x2013;<lpage>1459</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.30022</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caballol</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mart&#xed;</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Tolosa</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Cognitive dysfunction and dementia in Parkinson disease</article-title>. <source>Mov. Disord. official J. Mov. Disord. Soc.</source> <volume>22</volume>, <fpage>S358</fpage>&#x2013;<lpage>S366</lpage>. <pub-id pub-id-type="doi">10.1002/mds.21677</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calhoun</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Khoury</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Grossberg</surname>
<given-names>G. T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>An evaluation of memantine ER&#x2b; donepezil for the treatment of Alzheimer&#x2019;s disease</article-title>. <source>Expert Opin. Pharmacother.</source> <volume>19</volume>, <fpage>1711</fpage>&#x2013;<lpage>1717</lpage>. <pub-id pub-id-type="doi">10.1080/14656566.2018.1519022</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction</article-title>. <source>Hum. Exp. Toxicol.</source> <volume>30</volume>, <fpage>1657</fpage>&#x2013;<lpage>1665</lpage>. <pub-id pub-id-type="doi">10.1177/0960327110396530</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>G.-F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.-H.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.-R.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Melcher</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Amyloid beta: structure, biology and structure-based therapeutic development</article-title>. <source>Acta Pharmacol. Sin.</source> <volume>38</volume>, <fpage>1205</fpage>&#x2013;<lpage>1235</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2017.28</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Phenotypic characterization of the binding of tetracycline to human serum albumin</article-title>. <source>Biomacromolecules</source> <volume>12</volume>, <fpage>203</fpage>&#x2013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1021/bm1011568</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degregorio-Rocasolano</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mart&#xed;-Sistac</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gasull</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Deciphering the iron side of stroke: neurodegeneration at the crossroads between iron dyshomeostasis, excitotoxicity, and ferroptosis</article-title>. <source>Front. Neurosci.</source> <volume>13</volume>, <fpage>85</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2019.00085</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumurgier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sabia</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Life expectancy in dementia subtypes: exploring a leading cause of mortality</article-title>. <source>Lancet Healthy Longev.</source> <volume>2</volume>, <fpage>e449</fpage>&#x2013;<lpage>e450</lpage>. <pub-id pub-id-type="doi">10.1016/S2666-7568(21)00166-5</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fattori</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Hohmann</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Rossaneis</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Pinho-Ribeiro</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Verri</surname>
<given-names>W. A.</given-names>
<suffix>Jr</suffix>
</name>
</person-group> (<year>2016</year>). <article-title>Capsaicin: current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses</article-title>. <source>Molecules</source> <volume>21</volume>, <fpage>844</fpage>. <pub-id pub-id-type="doi">10.3390/molecules21070844</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Capsaicin, a tasty free radical scavenger: mechanism of action and kinetics</article-title>. <source>J. Phys. Chem. B</source> <volume>116</volume>, <fpage>1200</fpage>&#x2013;<lpage>1208</lpage>. <pub-id pub-id-type="doi">10.1021/jp211172f</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gl&#xe4;ttli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Daura</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Van Gunsteren</surname>
<given-names>W. F.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Derivation of an improved simple point charge model for liquid water: SPC/A and SPC/L</article-title>. <source>J. Chem. Phys.</source> <volume>116</volume>, <fpage>9811</fpage>&#x2013;<lpage>9828</lpage>. <pub-id pub-id-type="doi">10.1063/1.1476316</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gleitze</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Paula-Lima</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>N&#xfa;&#xf1;ez</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Hidalgo</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The calcium&#x2013;iron connection in ferroptosis-mediated neuronal death</article-title>. <source>Free Radic. Biol. Med.</source> <volume>175</volume>, <fpage>28</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2021.08.231</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Mondragon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vazquez-Tzompantzi</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Chemical and pharmacological aspects of capsaicin</article-title>. <source>Mol. Basel, Switz.</source> <volume>16</volume>, <fpage>1253</fpage>&#x2013;<lpage>1270</lpage>. <pub-id pub-id-type="doi">10.3390/molecules16021253</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gosriwatana</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Loreal</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brissot</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hider</surname>
<given-names>R. C.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin</article-title>. <source>Anal. Biochem.</source> <volume>273</volume>, <fpage>212</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1006/abio.1999.4216</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huey</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Forli</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Using AutoDock 4 and AutoDock vina with AutoDockTools: a tutorial</article-title>. <source>Scripps Res. Inst. Mol. Graph. Laboratory</source> <volume>10550</volume>, <fpage>1000</fpage>.</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.-T.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Epidemiology and etiology of Alzheimer&#x2019;s disease: from genetic to non-genetic factors</article-title>. <source>Curr. Alzheimer Res.</source> <volume>10</volume>, <fpage>852</fpage>&#x2013;<lpage>867</lpage>. <pub-id pub-id-type="doi">10.2174/15672050113109990155</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Khatibi</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Jadhav</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Charles</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Buchholz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <source>Capsaicin pre-treatment provides neurovascular protection against neonatal hypoxic-ischemic brain injury in rats</source>. <publisher-name>Springer</publisher-name>.</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leverence</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Kaltashov</surname>
<given-names>I. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Noncanonical interactions between serum transferrin and transferrin receptor evaluated with electrospray ionization mass spectrometry</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>107</volume>, <fpage>8123</fpage>&#x2013;<lpage>8128</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0914898107</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>X.-L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.-L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The associations between a capsaicin-rich diet and blood amyloid-&#x3b2; levels and cognitive function</article-title>. <source>J. Alzheimer&#x27;s Dis.</source> <volume>52</volume>, <fpage>1081</fpage>&#x2013;<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-151079</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lobanov</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Bogatyreva</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Galzitskaya</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Radius of gyration as an indicator of protein structure compactness</article-title>. <source>Mol. Biol.</source> <volume>42</volume>, <fpage>623</fpage>&#x2013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1134/s0026893308040195</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Capsaicin&#x2014;the major bioactive ingredient of chili peppers: Bio-efficacy and delivery systems</article-title>. <source>Food &#x26; Funct.</source> <volume>11</volume>, <fpage>2848</fpage>&#x2013;<lpage>2860</lpage>. <pub-id pub-id-type="doi">10.1039/d0fo00351d</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malafaia</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Albuquerque</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Amyloid-&#x3b2; and tau aggregation dual-inhibitors: a synthetic and structure-activity relationship focused review</article-title>. <source>Eur. J. Med. Chem.</source> <volume>214</volume>, <fpage>113209</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2021.113209</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marsh</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Teichmann</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Relative solvent accessible surface area predicts protein conformational changes upon binding</article-title>. <source>Structure</source> <volume>19</volume>, <fpage>859</fpage>&#x2013;<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2011.03.010</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maruyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ushiku</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mitsutake</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Analysis of protein folding simulation with moving root mean square deviation</article-title>. <source>J. Chem. Inf. Model.</source> <volume>63</volume>, <fpage>1529</fpage>&#x2013;<lpage>1541</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.2c01444</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mathur</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>M. I.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>InstaDock: a single-click graphical user interface for molecular docking-based virtual high-throughput screening</article-title>. <source>Briefings Bioinforma.</source> <volume>22</volume>, <fpage>bbaa279</fpage>. <pub-id pub-id-type="doi">10.1093/bib/bbaa279</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noinaj</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Easley</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Oke</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gumbart</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Boura</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Structural basis for iron piracy by pathogenic Neisseria</article-title>. <source>Nature</source> <volume>483</volume>, <fpage>53</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1038/nature10823</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onukwufor</surname>
<given-names>J. O.</given-names>
</name>
<name>
<surname>Dirksen</surname>
<given-names>R. T.</given-names>
</name>
<name>
<surname>Wojtovich</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Iron dysregulation in mitochondrial dysfunction and Alzheimer&#x2019;s disease</article-title>. <source>Antioxidants</source> <volume>11</volume>, <fpage>692</fpage>. <pub-id pub-id-type="doi">10.3390/antiox11040692</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozcan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Akpinar-Bayizit</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yilmaz-Ersan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Delikanli</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Phenolics in human health</article-title>. <source>Int. J. Chem. Eng. Appl.</source> <volume>5</volume>, <fpage>393</fpage>&#x2013;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.7763/ijcea.2014.v5.416</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Iron homeostasis disorder and Alzheimer&#x2019;s disease</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>, <fpage>12442</fpage>. <pub-id pub-id-type="doi">10.3390/ijms222212442</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Posner</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>M.-X.</given-names>
</name>
<name>
<surname>Luchsinger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lantigua</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mayeux</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function</article-title>. <source>Neurology</source> <volume>58</volume>, <fpage>1175</fpage>&#x2013;<lpage>1181</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.58.8.1175</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rollyson</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Stover</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Mcnees</surname>
<given-names>C. A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Bioavailability of capsaicin and its implications for drug delivery</article-title>. <source>J. Control. release</source> <volume>196</volume>, <fpage>96</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2014.09.027</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarzehi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chamani</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Investigation on the interaction between tamoxifen and human holo-transferrin: determination of the binding mechanism by fluorescence quenching, resonance light scattering and circular dichroism methods</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>47</volume>, <fpage>558</fpage>&#x2013;<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2010.08.002</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shamsi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anwar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Alajmi</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>M. T.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>MARK4 inhibited by AChE inhibitors, donepezil and Rivastigmine tartrate: insights into Alzheimer&#x2019;s disease therapy</article-title>. <source>Biomolecules</source> <volume>10</volume>, <fpage>789</fpage>. <pub-id pub-id-type="doi">10.3390/biom10050789</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Amna</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Amina</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Al-Musayeib</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Al-Deyab</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Influence of capsaicin on inflammatory cytokines induced by lipopolysaccharide in myoblast cells under <italic>in vitro</italic> environment</article-title>. <source>Pharmacogn. Mag.</source> <volume>13</volume>, <fpage>S26</fpage>&#x2013;<lpage>S32</lpage>. <pub-id pub-id-type="doi">10.4103/0973-1296.203984</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stein</surname>
<given-names>S. a.M.</given-names>
</name>
<name>
<surname>Loccisano</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Firestine</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Evanseck</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Principal components analysis: a review of its application on molecular dynamics data</article-title>. <source>Annu. Rep. Comput. Chem.</source> <volume>2</volume>, <fpage>233</fpage>&#x2013;<lpage>261</lpage>.</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Capsaicin attenuates LPS-induced inflammatory cytokine production by upregulation of LXR&#x3b1;</article-title>. <source>Int. Immunopharmacol.</source> <volume>28</volume>, <fpage>264</fpage>&#x2013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2015.06.007</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>D.-Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.-L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Spicy food consumption is associated with cognition and cerebrospinal fluid biomarkers of Alzheimer disease</article-title>. <source>Chin. Med. J.</source> <volume>134</volume>, <fpage>173</fpage>&#x2013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1097/CM9.0000000000001318</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2005</year>). <source>XMGRACE, version 5.1. 19</source>. <publisher-loc>Beaverton, OR</publisher-loc>: <publisher-name>Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology</publisher-name>.</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uddin</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Kabir</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Niaz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jeandet</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cl&#xe9;ment</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mathew</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Molecular insight into the therapeutic promise of flavonoids against Alzheimer&#x2019;s disease</article-title>. <source>Molecules</source> <volume>25</volume>, <fpage>1267</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25061267</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Der Spoel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lindahl</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Groenhof</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mark</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Berendsen</surname>
<given-names>H. J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>GROMACS: fast, flexible, and free</article-title>. <source>J. Comput. Chem.</source> <volume>26</volume>, <fpage>1701</fpage>&#x2013;<lpage>1718</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20291</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rausch</surname>
<given-names>W.-D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Iron dyshomeostasis and ferroptosis: a new alzheimer&#x2019;s disease hypothesis?</article-title> <source>Front. Aging Neurosci.</source> <volume>14</volume>, <fpage>830569</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2022.830569</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S.-F.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y.-G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.-B.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Iron pathophysiology in Alzheimer&#x2019;s diseases. Brain Iron metabolism and CNS diseases</article-title>. <source>Adv. Exp. Med. Biol.</source>, <fpage>67</fpage>&#x2013;<lpage>104</lpage>.</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Zucca</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Duyn</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Crichton</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Zecca</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The role of iron in brain ageing and neurodegenerative disorders</article-title>. <source>Lancet Neurology</source> <volume>13</volume>, <fpage>1045</fpage>&#x2013;<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(14)70117-6</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wegmann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Biernat</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mandelkow</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>A current view on Tau protein phosphorylation in Alzheimer&#x27;s disease</article-title>. <source>Curr. Opin. Neurobiol.</source> <volume>69</volume>, <fpage>131</fpage>&#x2013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2021.03.003</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Kemper</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Interventions to reduce cognitive decline in aging</article-title>. <source>J. Psychosoc. Nurs. Ment. health Serv.</source> <volume>48</volume>, <fpage>42</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.3928/02793695-20100331-03</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats</article-title>. <source>PloS one</source> <volume>12</volume>, <fpage>e0172477</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0172477</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yunta</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>It is important to compute intramolecular hydrogen bonding in drug design</article-title>. <source>Am. J. Model. Optim.</source> <volume>5</volume>, <fpage>24</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.12691/ajmo-5-1-3</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>New insights into the role of ferritin in iron homeostasis and neurodegenerative diseases</article-title>. <source>Mol. Neurobiol.</source> <volume>58</volume>, <fpage>2812</fpage>&#x2013;<lpage>2823</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-020-02277-7</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>